. 2021 Jan 11;1-7.
doi: 10.1080/15321819.2020.1862863.
Online ahead of print.
Affiliations
- PMID: 33428525
- DOI: 10.1080/15321819.2020.1862863
Abstract
Cannabidiol (CBD) is one of the most popular emerging plant extracts that is being investigated for its wide range of potential health benefits. This experiment tests how B16 mice melanoma cells, are affected by four different concentrations (0.2 mg/mL, 0.04 mg/mL, 0.008 mg/mL and 0.0016 mg/mL) of 99% CBD oil. The results of this experiment demonstrate that CBD significantly inhibited melanoma cell growth in-vitro at 0.2 mg/mL and 0.04 mg/mL. This shows that CBD has the potential to inhibit melanoma cell growth in vertebrates, namely mice.
Keywords: in vitro, CBD, Cannabidiol, melanoma, mice, spleen T cells, spleen cells
Similar articles
-
Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations.Molecules. 2018 May 20;23(5):1230. doi: 10.3390/molecules23051230.PMID: 29783790 Free PMC article.
-
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.J Neuroinflammation. 2016 Jun 3;13(1):136. doi: 10.1186/s12974-016-0603-x.PMID: 27256343 Free PMC article.
-
Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.Int J Mol Sci. 2019 Nov 25;20(23):5905. doi: 10.3390/ijms20235905.PMID: 31775230 Free PMC article. Review.
-
DMH-CBD, a cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor.Toxicol Appl Pharmacol. 2019 Apr 1;368:63-71. doi: 10.1016/j.taap.2019.02.011. Epub 2019 Feb 20.PMID: 30796934
-
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products.Ther Adv Psychopharmacol. 2020 Sep 9;10:2045125320954992. doi: 10.1177/2045125320954992. eCollection 2020.PMID: 32973998 Free PMC article. Review.
